Aarti Pharma Labs
add_icon

Aarti Pharma Labs

628.30
-15.45
(-2.40%)
Market Cap
5,696.03 Cr
PE Ratio
33.40
Volume
2,75,469.00
Day High - Low
653.75 - 623.15
52W High-Low
971.00 - 585.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
5,696.03 Cr
EPS
19.27
PE Ratio
33.40
PB Ratio
2.75
Book Value
234.35
EBITDA
366.41
Dividend Yield
0.54 %
Industry
Healthcare
Return on Equity
13.69
Debt to Equity
0.19
Analyst Rating and Forecast
- By Refinitiv from1 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+100.00 %
+100.00 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
Aarti Pharma Labs Q4 Profit Falls to 611M Rupees YoYMay 26, 2026
Aarti Pharma Labs reports Q4 consolidated net profit of 611M Rupees vs 883M YoY. EBITDA declined to 1.1B Rupees; margin contracted to 19.42% from 25.39%.
neutral
AARTI PHARMALABS LIMITED will meet investors and analysts on May 28, 2026, at the 360 ONE Capital Conference. The meeting will be held in physical mode.
neutral
Aarti Pharmalabs Limited has scheduled an earnings conference call for May 26, 2026, to discuss its Q4 FY26 financial results. The meeting will be held at 4:00 PM IST.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,782.20
#1 4,27,609.48
37.09
#1 58,220.10
6.38
#1 11,565
25.80
43.33
6,623.00
1,75,819.84
68.17
10,560.00
8.73
2,520
13.44
49.66
4,420.90
1,49,623.34
68.66
13,886.20
20.34
2,138
-26.91
53.32
1,401.30
1,13,194.31
29.24
27,711.70
-2.46
3,783
-55.32
58.57
1,089.00
1,09,578.88
21.32
26,719.70
13.65
5,242
7.82
71.01
1,278.20
1,06,684.07
25.44
33,593.30
-0.44
3,998
-86.05
45.82
2,267.70
1,03,643.69
#1 19.20
27,487.50
19.98
5,345
#1 87.72
47.04
2,336.10
96,435.39
50.16
14,277.60
12.03
1,750
31.75
47.08
1,462.30
84,930.62
24.27
33,384.70
3.21
3,376
1.99
53.78
1,446.80
78,106.45
86.55
6,812.90
#1 21.03
884
21.18
80.98

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-14.39 %
Net Income Growth
-29.97 %
Cash Flow Change
53.25 %
ROE
10.94 %
ROCE
2.38 %
EBITDA Margin (Avg.)
-10.70 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
463
457
532
472
486
459
441
450
508
558
463
543
562
388
418
437
596
Expenses
385
371
441
385
405
374
352
353
388
459
364
409
418
293
344
333
470
EBITDA
78
86
91
87
81
85
89
97
120
99
98
134
144
95
74
104
127
Operating Profit %
16 %
19 %
17 %
18 %
16 %
19 %
20 %
21 %
23 %
17 %
20 %
24 %
26 %
24 %
18 %
23 %
19 %
Depreciation
14
14
17
16
16
17
18
19
19
20
21
23
23
23
25
29
28
Interest
5
4
6
5
6
4
4
5
5
5
6
10
7
7
11
13
17
Profit Before Tax
60
68
69
65
59
64
67
74
96
74
72
101
115
65
39
63
82
Tax
11
16
18
17
16
17
15
21
31
18
17
27
26
16
11
15
21
Net Profit
49
52
51
48
43
47
52
53
65
56
55
74
88
50
28
48
61
EPS in ₹
5.39
5.72
5.64
5.26
4.73
5.20
5.72
5.82
7.20
6.12
6.03
8.16
9.75
5.46
3.08
5.29
6.74

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
0
2,040
2,244
2,582
2,906
3,482
Fixed Assets
0
782
926
1,033
1,137
1,831
Current Assets
0
1,028
1,163
1,346
1,322
1,397
Capital Work in Progress
0
187
102
137
374
305
Investments
0
32
87
107
77
640
Other Assets
0
1,038
1,130
1,305
1,319
0
Total Equity & Liabilities
0
2,040
2,244
2,582
2,906
3,482
Current Liabilities
0
581
601
694
657
938
Non Current Liabilities
0
73
85
131
259
420
Total Equity
0
1,387
1,559
1,757
1,990
2,125
Reserve & Surplus
0
1,341
1,513
1,712
1,945
2,079
Share Capital
0
0
45
45
45
45

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
0
78
-71
12
-17
Investing Activities
0
-139
-158
-215
-414
Operating Activities
0
-44
250
216
332
Financing Activities
0
260
-164
10
65

Share Holding

% Holding
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
44.16 %
45.98 %
45.98 %
46.30 %
46.46 %
46.46 %
46.46 %
46.10 %
44.66 %
44.29 %
43.72 %
42.88 %
43.10 %
43.08 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
8.16 %
8.32 %
7.06 %
7.38 %
8.64 %
7.36 %
7.35 %
8.02 %
7.68 %
8.39 %
DIIs
14.73 %
13.70 %
10.66 %
10.51 %
9.91 %
9.97 %
11.47 %
11.35 %
10.36 %
7.53 %
7.80 %
6.96 %
7.66 %
7.41 %
Government
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
24.66 %
28.35 %
30.23 %
29.13 %
29.74 %
29.71 %
29.57 %
29.45 %
30.39 %
34.10 %
34.43 %
35.39 %
34.85 %
34.29 %
Others
16.44 %
11.96 %
13.12 %
14.04 %
5.72 %
5.52 %
5.43 %
5.71 %
5.94 %
6.71 %
6.69 %
6.74 %
6.70 %
6.82 %
No of Share Holders
3,05,456
2,76,664
2,58,236
2,26,286
2,15,796
2,04,122
1,89,012
1,85,436
1,85,111
1,96,314
1,87,039
1,90,655
1,84,489
1,79,373

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 2 3 5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.4 0.84 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Feb 2024 DIVIDEND Dividend
₹ 2.00 /share
16 Feb 2024 550.70 536.20
31 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
31 Jul 2024 502.45 614.95
07 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
07 Aug 2024 608.50 595.85
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 610.40 605.40
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 599.00 623.00
14 Feb 2025 DIVIDEND Dividend
₹ 2.50 /share
14 Feb 2025 623.00 733.45
10 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 May 2025 754.25 767.35
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 911.20 857.15
15 Sept 2025 DIVIDEND Dividend
₹ 2.50 /share
15 Sept 2025 767.35 926.55
22 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Sept 2025 845.95 930.20
09 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2025 832.20 864.95
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2026 762.30 777.60
16 Feb 2026 DIVIDEND Dividend
₹ 1.50 /share
16 Feb 2026 777.60 709.20
25 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 May 2026 766.20 713.10

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome10 days ago
Compliances-Reg.24(A)-Annual Secretarial Compliance10 days ago
Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2026
Audited Financial Results For The Quarter And Financial Year Ended March 31 2026May 26, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
Grant Of Options Under APL Performance Stock Option Plan- 2023May 25, 2026
Re-Appointment Of Cost Auditor & Internal Auditor For FY 2026-2027May 25, 2026
Corporate Action-Board to consider DividendMay 25, 2026
Board Meeting Outcome for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended On 31 March 2026 And Recommending Final Dividend.May 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2026
Update on board meetingMay 14, 2026
Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31 2026 And Recommendation Of Final Dividend If Any.May 11, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 07, 2026
Intimation Regarding Second 100-Day Campaign - Saksham NiveshakApr 04, 2026
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Apr 04, 2026
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Apr 04, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 04, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 04, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 27, 2026
Closure of Trading WindowMar 25, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 16, 2026
Clarification Regarding Delay In Disclosure Of Event To The ExchangeFeb 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2026
Corrigendum To Intimation Of Record Date For Dividend Dated February 09 2026.Feb 10, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 09, 2026
Fixation Of Record Date For Interim DividendFeb 09, 2026
Corporate Action-Board approves DividendFeb 09, 2026
Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 09, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On February 9 2026Feb 09, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2025 2. Declaration Of Interim Dividend If Any On The Equity Share Capital Of The Company For The FiJan 29, 2026
Clarification With Respect To Increase In VolumeJan 12, 2026
Clarification sought from Aarti Pharmalabs LtdJan 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 01, 2026
Closure of Trading WindowDec 22, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2025
Financial Results For Quarter And Half Year Ended September 30 2025Nov 09, 2025

Technical Indicators

RSI(14)
Neutral
40.09
ATR(14)
Volatile
29.24
STOCH(9,6)
Oversold
12.05
STOCH RSI(14)
Oversold
12.15
MACD(12,26)
Bearish
-10.02
ADX(14)
Weak Trend
20.01
UO(9)
Bearish
34.02
ROC(12)
Downtrend And Accelerating
-8.21
WillR(14)
Neutral
-71.59